GTBP icon

GT Biopharma
GTBP

Overview Fund Trends Analyst Outlook Journalist POV

35 hedge funds and large institutions have $1.11M invested in GT Biopharma in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

less ownership

Funds ownership: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

63% less capital invested

Capital invested by funds: $3.05M → $1.11M (-$1.93M)

Holders
35
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$61.5K
2
+$28.7K
3
+$7.17K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$6.63K
5
MCG
McCollum Christoferson Group
New York
+$5.46K

Top Sellers

1
-$1.21M
2
-$21.9K
3
-$20.4K
4
Jane Street
Jane Street
New York
-$9.4K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$8.75K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$2K
27
$946
28
$810
29
$316
30
$171
31
$94
32
$16
33
$14
34
–
35
–
36
–
37
–
38
–
1
2